Your browser doesn't support javascript.
loading
Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma.
Pourmaleki, Maryam; Jones, Caitlin J; Ariyan, Charlotte E; Zeng, Zheng; Pirun, Mono; Navarrete, Daniel A; Li, Yanyun; Zhang, Mianlei; Nandakumar, Subhiksha; Campos, Carl; Nadeem, Saad; Klimstra, David S; Temple-Oberle, Claire F; Brenn, Thomas; Lipson, Evan J; Schenk, Kara M; Stein, Julie E; Taube, Janis M; White, Michael G; Traweek, Raymond; Wargo, Jennifer A; Kirkwood, John M; Gasmi, Billel; Goff, Stephanie L; Corwin, Alex D; McDonough, Elizabeth; Ginty, Fiona; Callahan, Margaret K; Schietinger, Andrea; Socci, Nicholas D; Mellinghoff, Ingo K; Hollmann, Travis J.
Afiliação
  • Pourmaleki M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Jones CJ; Tri-Institutional Program in Computational Biology and Medicine, Weill Cornell School of Medicine, New York, New York.
  • Ariyan CE; Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Zeng Z; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Pirun M; Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Navarrete DA; Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Li Y; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Zhang M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Nandakumar S; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Campos C; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Nadeem S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Klimstra DS; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Temple-Oberle CF; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Brenn T; Department of Surgery, University of Calgary, Calgary, Alberta, Canada.
  • Lipson EJ; Department of Oncology, University of Calgary, Calgary, Alberta, Canada.
  • Schenk KM; Department of Pathology, University of Calgary, Calgary, Alberta, Canada.
  • Stein JE; Department of Oncology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland.
  • Taube JM; Department of Oncology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland.
  • White MG; Department of Pathology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland.
  • Traweek R; Department of Oncology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland.
  • Wargo JA; Department of Pathology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland.
  • Kirkwood JM; Department of Dermatology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland.
  • Gasmi B; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Goff SL; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Corwin AD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • McDonough E; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ginty F; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Callahan MK; Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Schietinger A; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Socci ND; Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Mellinghoff IK; Biology and Applied Physics, GE Global Research Center, Niskayuna, New York.
  • Hollmann TJ; Biology and Applied Physics, GE Global Research Center, Niskayuna, New York.
Cancer Immunol Res ; 10(3): 303-313, 2022 03 01.
Article em En | MEDLINE | ID: mdl-35013003
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-2 / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-2 / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article